{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:08:26Z","timestamp":1791270506723,"version":"4.1.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.antiviral.2013.09.013","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T00:49:57Z","timestamp":1380242997000},"page":"500-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":323,"title":["Ten years of dengue drug discovery: Progress and prospects"],"prefix":"10.1016","volume":"100","author":[{"given":"Siew Pheng","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Yin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Yokokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahul","family":"Nilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Lescar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.09.013_b0005","doi-asserted-by":"crossref","first-page":"39926","DOI":"10.1074\/jbc.M104248200","article-title":"De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase","volume":"276","author":"Ackermann","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0010","doi-asserted-by":"crossref","first-page":"628475","DOI":"10.1155\/2012\/628475","article-title":"Dengue virus entry as target for antiviral therapy","volume":"2012","author":"Alen","year":"2012","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.antiviral.2013.09.013_b0015","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1016\/j.bmc.2012.04.055","article-title":"Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold","volume":"20","author":"Aravapalli","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4269\/ajtmh.2011.10-0521","article-title":"Health economics of dengue: a systematic literature review and expert panel\u2019s assessment","volume":"84","author":"Beatty","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2013.09.013_b0025","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.09.013_b0030","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.2174\/092986711795656180","article-title":"Twenty years of HIV-1 non-nucleoside reverse transcriptase inhibitors: time to reevaluate their toxicity","volume":"18","author":"Blas-Garcia","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ab.2009.08.013","article-title":"A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease","volume":"395","author":"Bodenreider","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2009.11.009","article-title":"Structure and functionality in flavivirus NS-proteins: perspectives for drug design","volume":"87","author":"Bollati","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0045","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1073\/pnas.1017142108","article-title":"Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV)","volume":"108","author":"Bonavia","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.09.013_b0050","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/03639040701836636","article-title":"Physicochemical properties of the nucleoside prodrug R1626 leading to high oral bioavailability","volume":"34","author":"Brandl","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.antiviral.2013.09.013_b0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.01429-12","article-title":"A novel inhibitor of dengue virus replication that targets the capsid protein","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0060","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/AAC.02251-12","article-title":"Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0065","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1021\/bi991992s","article-title":"Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: implications for viral replication and in vitro assays","volume":"39","author":"Carroll","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2013.09.013_b0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/0-306-46812-3_12","article-title":"Nucleoside transporters of mammalian cells","volume":"12","author":"Cass","year":"1999","journal-title":"Pharm. Biotechnol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0075","doi-asserted-by":"crossref","first-page":"e39652","DOI":"10.1371\/journal.pone.0039652","article-title":"HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors","volume":"7","author":"Cento","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.09.013_b0080","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/AAC.00140-10","article-title":"Inhibition of dengue virus RNA synthesis by an adenosine nucleoside","volume":"54","author":"Chen","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0085","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1128\/AAC.00397-10","article-title":"Inhibition of dengue virus by an ester prodrug of an adenosine analog","volume":"54","author":"Chen","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jviromet.2010.06.013","article-title":"A method for full genome sequencing of all four serotypes of the dengue virus","volume":"169","author":"Christenbury","year":"2010","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2013.09.013_b0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.virol.2010.03.011","article-title":"Higher catalytic efficiency of N-7-methylation is responsible for processive N-7 and 2\u2032-O methyltransferase activity in dengue virus","volume":"402","author":"Chung","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.09.013_b0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2009.09.014","article-title":"Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine","volume":"85","author":"Cihlar","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0105","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1371\/journal.pntd.0000721","article-title":"Structural optimization and de novo design of dengue virus entry inhibitory peptides","volume":"4","author":"Costin","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3851\/IMP1767","article-title":"Small molecule pan-dengue and West Nile virus NS3 protease inhibitors","volume":"21","author":"Cregar-Hernandez","year":"2011","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0115","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature09489","article-title":"2\u2032-O methylation of the viral mRNA cap evades host restriction by IFIT family members","volume":"468","author":"Daffis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.09.013_b0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1567-7249(02)00003-X","article-title":"Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence?","volume":"1","author":"Dagan","year":"2002","journal-title":"Mitochondrion"},{"key":"10.1016\/j.antiviral.2013.09.013_b0125","doi-asserted-by":"crossref","first-page":"e37244","DOI":"10.1371\/journal.pone.0037244","article-title":"An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro","volume":"7","author":"De Burghgraeve","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.09.013_b0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijantimicag.2008.10.010","article-title":"Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV","volume":"33","author":"De Clercq","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.antiviral.2013.09.013_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pharmtox-010510-100228","article-title":"A 40-year journey in search of selective antiviral chemotherapy","volume":"51","author":"De Clercq","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-540-79086-0_3","article-title":"Antiviral agents acting as DNA or RNA chain terminators","author":"De Clercq","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0145","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/AAC.00294-11","article-title":"Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replication","volume":"55","author":"Delang","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0150","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1021\/jm300146f","article-title":"Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping","volume":"55","author":"Deng","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0155","first-page":"231","article-title":"Antibody therapeutics against flaviviruses","author":"Diamond","year":"2012","journal-title":"Mol. Virol. Contr. Flavivir."},{"key":"10.1016\/j.antiviral.2013.09.013_b0160","doi-asserted-by":"crossref","first-page":"e1002642","DOI":"10.1371\/journal.ppat.1002642","article-title":"2\u2032-O methylation of internal adenosine by flavivirus NS5 methyltransferase","volume":"8","author":"Dong","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.09.013_b0165","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.virol.2010.06.039","article-title":"Biochemical and genetic characterization of dengue virus methyltransferase","volume":"405","author":"Dong","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.09.013_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2008.05.003","article-title":"Flavivirus methyltransferase: a novel antiviral target","volume":"80","author":"Dong","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0175","first-page":"860","article-title":"Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection","volume":"10","author":"Durantel","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.antiviral.2013.09.013_b0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.virol.2008.03.028","article-title":"Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever","volume":"376","author":"Durbin","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.09.013_b0185","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/emboj\/21.11.2757","article-title":"An RNA cap (nucleoside-2\u2032-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization","volume":"21","author":"Egloff","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2013.09.013_b0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/653080","article-title":"The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitors","volume":"202","author":"Einav","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"2","key":"10.1016\/j.antiviral.2013.09.013_b0200","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1371\/journal.pntd.0000086","article-title":"Host gene expression profiling of dengue virus infection in cell lines and patients","volume":"1","author":"Fink","year":"2007","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0205","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.mib.2011.07.012","article-title":"Exploitation of cellular pathways by Dengue virus","volume":"14","author":"Fischl","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0210","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200009290-00010","article-title":"Zidovudine triphosphate and lamivudine triphosphate concentration\u2013response relationships in HIV-infected persons","volume":"14","author":"Fletcher","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2013.09.013_b0215","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature08960","article-title":"Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect","volume":"465","author":"Gao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.09.013_b0220","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1172\/JCI116463","article-title":"Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells","volume":"91","author":"Gao","year":"1993","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.antiviral.2013.09.013_b0225","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1128\/JVI.00311-11","article-title":"Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors","volume":"85","author":"Garcia-Lerma","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0230","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/528805","article-title":"Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response","volume":"197","author":"Guilarde","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0235","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jhep.2011.01.011","article-title":"Hepatitis C virus resistance to protease inhibitors","volume":"55","author":"Halfon","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1743-422X-2-49","article-title":"Peptide inhibitors of dengue virus and West Nile virus infectivity","volume":"2","author":"Hrobowski","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2013.09.013_b0245","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/383043","article-title":"Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization","volume":"189","author":"Jessie","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0250","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.antiviral.2009.09.007","article-title":"In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses","volume":"84","author":"Kampmann","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0255","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1021\/pr100219y","article-title":"The ubiquitin-proteasome pathway is important for dengue virus infection in primary human endothelial cells","volume":"9","author":"Kanlaya","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0260","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/AAC.00686-10","article-title":"A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro","volume":"54","author":"Kaptein","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-60327-355-8_15","article-title":"Fluorometric assay of hepatitis C virus NS3 helicase activity","volume":"587","author":"Krawczyk","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0270","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2013.09.013_b0275","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1128\/JVI.76.10.4773-4784.2002","article-title":"Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles","volume":"76","author":"Kummerer","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0280","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep.22549","article-title":"Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naive patients","volume":"48","author":"Kuntzen","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2013.09.013_b0285","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bmc.2012.10.058","article-title":"Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of Dengue and West Nile virus NS2B\/NS3 proteases","volume":"21","author":"Lai","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0290","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.antiviral.2012.10.009","article-title":"Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in vitro","volume":"97","author":"Lai","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0295","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00002030-200303280-00007","article-title":"A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy","volume":"17","author":"Lalezari","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2013.09.013_b0300","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm0897-922","article-title":"The bottleneck in AZT activation","volume":"3","author":"Lavie","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2013.09.013_b0305","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1128\/JVI.00117-08","article-title":"Cholesterol effectively blocks entry of flavivirus","volume":"82","author":"Lee","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0310","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2008.07.001","article-title":"Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target","volume":"80","author":"Lescar","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0315","doi-asserted-by":"crossref","first-page":"45762","DOI":"10.1074\/jbc.M107360200","article-title":"Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors","volume":"276","author":"Leung","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0320","doi-asserted-by":"crossref","first-page":"28766","DOI":"10.1074\/jbc.M500588200","article-title":"Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0325","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane\u2013envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.09.013_b0330","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1083\/jcb.200507075","article-title":"Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion","volume":"171","author":"Liao","year":"2005","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0335","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/340365","article-title":"Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections","volume":"185","author":"Libraty","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0340","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/343813","article-title":"High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever","volume":"186","author":"Libraty","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0345","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1074\/jbc.M110.179184","article-title":"Small molecule inhibitors that selectively block dengue virus methyltransferase","volume":"286","author":"Lim","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0350","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.antiviral.2008.08.005","article-title":"A scintillation proximity assay for dengue virus NS5 2\u2032-O-methyltransferase-kinetic and inhibition analyses","volume":"80","author":"Lim","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0355","doi-asserted-by":"crossref","unstructured":"Lim., S.P., Bodenreider, C., Shi, P.Y., 2013. Detection and quantification of flavivirus NS5 methyl-transferase activities. In: Edwin Yunhao Gong (Ed.), Antiviral Methods and Protocols, second Ed., vol. 1030. Springer Protocols, Humana Press.","DOI":"10.1007\/978-1-62703-484-5_20"},{"key":"10.1016\/j.antiviral.2013.09.013_b0360","unstructured":"Lindenbach, B.D., Thiel, H.-J., Rice, C.M., 2007. Flaviviridae: the virus and their replication, In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, fifth Ed., vol. 1. Lippincott William & Wilkins, Philadelphia, PA, pp. 1101\u20131152"},{"key":"10.1016\/j.antiviral.2013.09.013_b0365","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0370","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1128\/JVI.77.14.7804-7813.2003","article-title":"Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication","volume":"77","author":"Liu","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0375","doi-asserted-by":"crossref","first-page":"e50995","DOI":"10.1371\/journal.pone.0050995","article-title":"Release of dengue virus genome induced by a peptide inhibitor","volume":"7","author":"Lok","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.antiviral.2013.09.013_b0380","doi-asserted-by":"crossref","first-page":"783","DOI":"10.47102\/annals-acadmedsg.V35N11p783","article-title":"Early Dengue infection and outcome study (EDEN) \u2013 study design and preliminary findings","volume":"35","author":"Low","year":"2006","journal-title":"Ann. Acad. Med. Singapore"},{"issue":"1","key":"10.1016\/j.antiviral.2013.09.013_b0385","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/JVI.01788-07","article-title":"Crystal structure of the NS3 protease-helicase from Dengue virus","volume":"82","author":"Luo","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0390","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/emboj.2008.232","article-title":"Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein","volume":"27","author":"Luo","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2013.09.013_b0395","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1073\/pnas.0305892101","article-title":"Solution structure of dengue virus capsid protein reveals another fold","volume":"101","author":"Ma","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.09.013_b0400","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1073\/pnas.0305892101","article-title":"Solution structure of dengue virus capsid protein reveals another fold","volume":"101","author":"Ma","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.09.013_b0405","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.1074\/jbc.M607273200","article-title":"Crystal structure of the RNA polymerase domain of the West Nile virus non-structural protein 5","volume":"282","author":"Malet","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0410","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2008.06.007","article-title":"The flavivirus polymerase as a target for drug discovery","volume":"80","author":"Malet","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0415","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0420","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1016\/j.bmcl.2010.06.094","article-title":"Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus","volume":"20","author":"McGuigan","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2013.09.013_b0425","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.2174\/092986711795933759","article-title":"Ligand and structure based virtual screening strategies for hit-finding and optimization of hepatitis C virus (HCV) inhibitors","volume":"18","author":"Melagraki","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0430","doi-asserted-by":"crossref","first-page":"49164","DOI":"10.1074\/jbc.M305041200","article-title":"Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro","volume":"278","author":"Migliaccio","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0435","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/AAC.01554-12","article-title":"Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo","volume":"56","author":"Miller","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0440","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1074\/jbc.M609919200","article-title":"The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner","volume":"282","author":"Miller","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0445","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.1074\/jbc.M512697200","article-title":"Subcellular localization and membrane topology of the dengue virus type 2 non-structural protein 4B","volume":"281","author":"Miller","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0450","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.09.013_b0455","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.09.013_b0460","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0465","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1073\/pnas.2335168100","article-title":"Inhibition of interferon signaling by dengue virus","volume":"100","author":"Munoz-Jordan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.09.013_b0470","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1665-2681(19)31482-6","article-title":"Balapiravir plus peginterferon alfa-2a (40KD)\/ribavirin in a randomized trial of hepatitis C genotype 1 patients","volume":"11","author":"Nelson","year":"2012","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0475","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.antiviral.2007.06.007","article-title":"Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing","volume":"76","author":"Ng","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0480","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/infdis\/jis470","article-title":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients","volume":"207","author":"Nguyen","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0485","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.antiviral.2010.11.008","article-title":"Viral entry inhibitors block dengue antibody-dependent enhancement in vitro","volume":"89","author":"Nicholson","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0490","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2012.02.008","article-title":"Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 protease","volume":"94","author":"Nitsche","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0495","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000321892","article-title":"Statins reduce dengue virus production via decreased virion assembly","volume":"54","author":"Niu","year":"2011","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2013.09.013_b0500","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1087057110389323","article-title":"A fluorescence-based alkaline phosphatase-coupled polymerase assay for identification of inhibitors of dengue virus RNA-dependent RNA polymerase","volume":"16","author":"Niyomrattanakit","year":"2010","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.antiviral.2013.09.013_b0505","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1128\/JVI.02451-09","article-title":"Inhibition of dengue virus polymerase by blocking of the RNA tunnel","volume":"84","author":"Niyomrattanakit","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0510","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.antiviral.2009.12.011","article-title":"Strategies for development of Dengue virus inhibitors","volume":"85","author":"Noble","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0515","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1128\/JVI.00045-13","article-title":"Conformational flexibility of the Dengue virus RNA-dependent RNA polymerase revealed by a complex with an inhibitor","volume":"87","author":"Noble","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0520","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/JVI.06225-11","article-title":"Ligand-bound structures of the dengue virus protease reveal the active conformation","volume":"86","author":"Noble","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0525","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.antiviral.2012.09.007","article-title":"Structural biology of dengue virus enzymes: towards rational design of therapeutics","volume":"96","author":"Noble","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0530","first-page":"164878","article-title":"Cells in dengue virus infection in vivo","volume":"2010","author":"Noisakran","year":"2010","journal-title":"Advan. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0535","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.1128\/JVI.01358-07","article-title":"Identification of novel small-molecule inhibitors of West Nile virus infection","volume":"81","author":"Noueiry","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0540","doi-asserted-by":"crossref","unstructured":"Novartis Foundation Symposium 277. 2006. In: Bock, G., Goode, J. (Eds.), New Treatment Strategies for Dengue and Other Flaviviral Diseases. John Wiley and Sons Ltd.","DOI":"10.1002\/0470058005"},{"key":"10.1016\/j.antiviral.2013.09.013_b0545","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/AAC.00074-09","article-title":"Identification of inhibitors of yellow fever virus replication using a replicon-based high-throughput assay","volume":"53","author":"Patkar","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0550","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Structural proteomics of dengue virus","volume":"11","author":"Perera","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0555","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1517\/14712598.2011.627851","article-title":"Drugs in development for chronic hepatitis C: a promising future","volume":"11","author":"Pockros","year":"2011","journal-title":"Exp. Opin. Biol. Ther."},{"key":"10.1016\/j.antiviral.2013.09.013_b0560","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cld.2012.09.004","article-title":"Non-nucleoside analogue polymerase inhibitors in development","volume":"17","author":"Pockros","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0565","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.antiviral.2009.09.011","article-title":"A small molecule fusion inhibitor of dengue virus","volume":"84","author":"Poh","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0570","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.virol.2008.04.032","article-title":"Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors","volume":"377","author":"Pugach","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.09.013_b0575","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1128\/AAC.01236-09","article-title":"Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors","volume":"54","author":"Puyang","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0580","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.antiviral.2010.02.313","article-title":"A high-throughput assay using dengue-1 virus-like particles for drug discovery","volume":"86","author":"Qing","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0585","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.antiviral.2011.10.002","article-title":"Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model","volume":"92","author":"Rathore","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0590","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1128\/JVI.00814-06","article-title":"West nile virus 5\u2032-cap structure is formed by sequential guanine N-7 and ribose 2\u2032-O methylations by nonstructural protein 5","volume":"80","author":"Ray","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0595","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.09.013_b0600","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4269\/ajtmh.1999.61.720","article-title":"Detection of dengue virus RNA by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection","volume":"61","author":"Rosen","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2013.09.013_b0605","first-page":"2117","article-title":"Phase I tolerance and pharmacokinetics of a new castanospermine derivative, MDL 28,574A","volume":"11","author":"Roth","year":"1996","journal-title":"Int. Conf. AIDS"},{"key":"10.1016\/j.antiviral.2013.09.013_b0610","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0615","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virol.2009.03.025","article-title":"Cholesterol biosynthesis modulation regulates dengue viral replication","volume":"389","author":"Rothwell","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.09.013_b0620","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1586\/14787210.4.6.953","article-title":"First demonstration of the effectiveness of inhibitors of cellular protein kinases in antiviral therapy","volume":"4","author":"Schang","year":"2006","journal-title":"Exp. Rev. Anti-infect. Ther."},{"key":"10.1016\/j.antiviral.2013.09.013_b0625","doi-asserted-by":"crossref","first-page":"e1002627","DOI":"10.1371\/journal.ppat.1002627","article-title":"Small-molecule inhibitors of dengue-virus entry","volume":"8","author":"Schmidt","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.09.013_b0630","doi-asserted-by":"crossref","first-page":"e1000851","DOI":"10.1371\/journal.ppat.1000851","article-title":"Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate","volume":"6","author":"Schmidt","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.09.013_b0635","doi-asserted-by":"crossref","first-page":"12549","DOI":"10.1128\/JVI.01440-10","article-title":"Peptide inhibitors of flavivirus entry derived from the E protein stem","volume":"84","author":"Schmidt","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0640","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1128\/JVI.02445-08","article-title":"Genomic epidemiology of a dengue virus epidemic in urban Singapore","volume":"83","author":"Schreiber","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0645","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/511310","article-title":"A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs","volume":"195","author":"Schul","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0650","doi-asserted-by":"crossref","unstructured":"Schwegmann, A., Brombacher, F., 2008. Host-directed drug targeting of factors hijacked by pathogens. Sci. Signaling 1, re8.","DOI":"10.1126\/scisignal.129re8"},{"key":"10.1016\/j.antiviral.2013.09.013_b0655","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1021\/bi3005126","article-title":"Fragment-based approaches in drug discovery and chemical biology","volume":"51","author":"Scott","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2013.09.013_b0660","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nature07967","article-title":"Discovery of insect and human dengue virus host factors","volume":"458","author":"Sessions","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.09.013_b0900","doi-asserted-by":"crossref","DOI":"10.1177\/1087057113482586","article-title":"Discovering new medicines targeting helicases: challenges and recent progress","author":"Shadrick","year":"2013","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.antiviral.2013.09.013_b0670","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/jm201384j","article-title":"Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase","volume":"55","author":"Sofia","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0675","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrmicro3030","article-title":"Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis","volume":"11","author":"St John","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0680","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1592\/phco.21.1.11.34439","article-title":"Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians","volume":"21","author":"Stein","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.antiviral.2013.09.013_b0685","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1016\/j.bmc.2011.05.015","article-title":"Synthesis and biological evaluation of alpha-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture","volume":"19","author":"Steuer","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0905","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/cis655","article-title":"Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial","volume":"55","author":"Tam","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0690","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nbt1207-1383","article-title":"Systems biology and the host response to viral infection","volume":"25","author":"Tan","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.antiviral.2013.09.013_b0695","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1371\/journal.pntd.0000196","article-title":"Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness","volume":"2","author":"Tanner","year":"2008","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0700","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2009.02.190","article-title":"Structure-based discovery of dengue virus protease inhibitors","volume":"82","author":"Tomlinson","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0705","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/1871526510909030327","article-title":"New approaches to structure-based discovery of dengue protease inhibitors","volume":"9","author":"Tomlinson","year":"2009","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.antiviral.2013.09.013_b0710","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.antiviral.2010.12.006","article-title":"Anthracene-based inhibitors of dengue virus NS2B-NS3 protease","volume":"89","author":"Tomlinson","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0715","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.antiviral.2011.12.003","article-title":"Use of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors","volume":"93","author":"Tomlinson","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0720","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/vir.0.81844-0","article-title":"Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA","volume":"87","author":"Umareddy","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0725","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1743-422X-4-91","article-title":"Dengue virus serotype infection specifies the activation of the unfolded protein response","volume":"4","author":"Umareddy","year":"2007","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2013.09.013_b0730","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1086\/339539","article-title":"Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever","volume":"34","author":"van Gorp","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0735","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/aid.1997.13.481","article-title":"In vitro screening of nucleoside analog combinations for potential use in anti-HIV therapy","volume":"13","author":"Veal","year":"1997","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.antiviral.2013.09.013_b0740","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11030-006-9040-6","article-title":"Leadlikeness and structural diversity of synthetic screening libraries","volume":"10","author":"Verheij","year":"2006","journal-title":"Mol. Divers"},{"key":"10.1016\/j.antiviral.2013.09.013_b0745","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4269\/ajtmh.2008.78.370","article-title":"Biochemical alterations as markers of dengue hemorrhagic fever","volume":"78","author":"Villar-Centeno","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2013.09.013_b0750","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","article-title":"The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus","volume":"58","author":"Volz","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0755","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/aid.2004.20.1173","article-title":"Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection","volume":"20","author":"Wang","year":"2004","journal-title":"AIDS Res. Hum. Retroviru."},{"key":"10.1016\/j.antiviral.2013.09.013_b0760","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1128\/JVI.02510-10","article-title":"Inhibition of dengue virus through suppression of host pyrimidine biosynthesis","volume":"85","author":"Wang","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0765","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1128\/AAC.00620-11","article-title":"A translation inhibitor that suppresses dengue virus in vitro and in vivo","volume":"55","author":"Wang","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0770","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/AAC.01148-08","article-title":"A small-molecule dengue virus entry inhibitor","volume":"53","author":"Wang","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0775","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/viro.2002.1704","article-title":"High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis","volume":"305","author":"Wang","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.09.013_b0780","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/507635","article-title":"Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever","volume":"43","author":"Wang","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0785","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2012.07.008","article-title":"Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial","volume":"96","author":"Watanabe","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0790","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2009.10.003","article-title":"Fifteen years of HIV protease inhibitors: raising the barrier to resistance","volume":"85","author":"Wensing","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0795","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1128\/JVI.79.14.8698-8706.2005","article-title":"Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo","volume":"79","author":"Whitby","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0800","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.antiviral.2012.12.027","article-title":"Resolution of the interaction mechanisms and characteristics of non-nucleoside inhibitors of hepatitis C virus polymerase","volume":"97","author":"Winquist","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.013_b0805","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.gastro.2010.06.042","article-title":"Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses","volume":"139","author":"Woo","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2013.09.013_b0810","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1128\/JVI.79.16.10268-10277.2005","article-title":"Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing","volume":"79","author":"Wu","year":"2005","journal-title":"J. Virol."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2013.09.013_b0815","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/infdis\/jis761","article-title":"Antiviral resistance and the future landscape of hepatitis C virus infection therapy","volume":"207","author":"Wyles","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.013_b0820","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1128\/JVI.05468-11","article-title":"Inhibition of dengue virus by targeting viral NS4B protein","volume":"85","author":"Xie","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0825","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1021\/jm300655h","article-title":"Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease","volume":"55","author":"Xu","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0830","doi-asserted-by":"crossref","first-page":"10278","DOI":"10.1128\/JVI.79.16.10278-10288.2005","article-title":"Structure of the Dengue virus helicase\/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A","volume":"79","author":"Xu","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0835","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.virol.2007.12.018","article-title":"Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase\/nucleoside triphosphatase at a resolution of 1.8 A","volume":"373","author":"Yamashita","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.09.013_b0840","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/AAC.00855-10","article-title":"Novel dengue virus-specific NS2B\/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay","volume":"55","author":"Yang","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0845","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1128\/JVI.02283-06","article-title":"Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution","volume":"81","author":"Yap","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0850","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1021\/jm901044z","article-title":"N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymerase","volume":"52","author":"Yin","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0855","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.09.013_b0860","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bmcl.2005.09.049","article-title":"Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors","volume":"16","author":"Yin","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2013.09.013_b0865","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1021\/jm300171v","article-title":"Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection","volume":"55","author":"Yu","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0875","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/AAC.01101-10","article-title":"Safety and pharmacokinetics of IDX184, a liver-targeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects","volume":"55","author":"Zhou","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.013_b0880","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1128\/JVI.02704-06","article-title":"Structure and function of flavivirus NS5 methyltransferase","volume":"81","author":"Zhou","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0885","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/cb800176t","article-title":"Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein","volume":"3","author":"Zhou","year":"2008","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.antiviral.2013.09.013_b0890","doi-asserted-by":"crossref","first-page":"14362","DOI":"10.1074\/jbc.M110.214189","article-title":"Functional analysis of two cavities in flavivirus NS5 polymerase","volume":"286","author":"Zou","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.09.013_b0895","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.virol.2008.11.003","article-title":"A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor","volume":"384","author":"Zou","year":"2008","journal-title":"Virology"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:17:53Z","timestamp":1715995073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213002611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":179,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0166354213002611"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.09.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten years of dengue drug discovery: Progress and prospects","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}